# DOD Neurofibromatosis, Clinical Trial Consortium Award

Source: https://welltoldgrants.com/grants/w81xwh-21-nfrp-ctca-dod-neurofibromatosis-clinical-trial-consortium-award/  
Official notice: https://www.grants.gov/search-results-detail/335360

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make one award worth $25.0 million in total. Applications closed on October 29, 2021.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-21-NFRP-CTCA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 29, 2021 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $25.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The NFRP Clinical Trial Consortium Award mechanism was first offered in FY06, and subsequently in FY11 and FY16, with awards being made as grants or cooperative agreements. This FY21 research announcement is being offered through a different type of award mechanism, a Research Other Transaction Award (rOTA) under the authority of 10 USC 2371. The FY21 NFRP Clinical Trial Consortium Award is intended to support a major goal/product-driven consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic NF research and ultimately decrease the impact of the disease. The objectives of the rOTA are the conception, design, development, and conduct of collaborative Phase I and II clinical evaluations of promising therapeutic agents for the management or treatment of NF1, NF2, and schwannomatosis. Research Other Transaction Agreement The principal purpose of a rOTA is to carry out non-duplicative basic, applied, and advanced research projects rather than the acquisition of property or services for the direct benefit or use of the government. The anticipated deliverables to the government under a rOTA are reports on research rather than prototypes. Additionally, a rOTA has several features that differ from those of the previous award types offered for the NFRP Clinical Trial Consortium. The rOTA requires resource sharing, with government funds not to exceed the total amount provided by other parties to the maximum extent practicable. Offerors will be required to demonstrate how resources (e.g., cash and non-cash) will be made available for this project. Please also note that the government’s funds will not be front-loaded, with certain matches being required before additional government funds are made available. The rOTA is intended to promote the use of best business practices and to foster relationships among performers from different sectors. In addition, as a matter of DOD policy, rOTAs may only be awarded when one or more for-profit firms are to be involved either in the: (1) performance of the research project(s) or (2) commercial application of the research results. A consortium should either include, collaborate with, or involve one or more for-profit firms in addition to state or local government agencies, institutions of higher education, or other nonprofit organizations.

## Questions people ask

### Is W81XWH-21-NFRP-CTCA still open?

No. It closed on October 29, 2021. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DOD Neurofibromatosis, Clinical Trial Consortium Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DOD Neurofibromatosis, Clinical Trial Consortium Award?

Closed October 29, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $25.0 million in total for one award.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.